Similar articles for PMID: 28982918

Year	Number of Results
1948	1
1963	1
1964	1
1987	1
1989	1
1996	1
1997	2
1998	1
1999	1
2002	1
2003	1
2004	3
2006	1
2007	2
2008	2
2009	2
2010	5
2011	11
2012	16
2013	12
2014	9
2015	17
2016	26
2017	17
2018	11
2019	12
2020	9
2021	4
2024	0

1

Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.

Jang JY, Pak KJ, Yi KI, Ki YK, Kim WT, Kim H, Choi YJ, Kim SJ, Kim IJ, Wang SG, Seol YM. Jang JY, et al. Anticancer Res. 2017 Oct;37(10):5899-5905. doi: 10.21873/anticanres.12036. Anticancer Res. 2017. PMID: 28982918

2

(¹⁸F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.

Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M. Scher N, et al. Cancer Radiother. 2018 May;22(3):229-235. doi: 10.1016/j.canrad.2017.10.003. Epub 2018 Apr 9. Cancer Radiother. 2018. PMID: 29650390

3

Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.

Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM. Higgins KA, et al. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-53. doi: 10.1016/j.ijrobp.2010.11.050. Epub 2011 Jan 27. Int J Radiat Oncol Biol Phys. 2012. PMID: 21277108

4

Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.

Martens RM, Noij DP, Koopman T, Zwezerijnen B, Heymans M, de Jong MC, Hoekstra OS, Vergeer MR, de Bree R, Leemans CR, de Graaf P, Boellaard R, Castelijns JA. Martens RM, et al. Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4. Eur J Radiol. 2019. PMID: 30927958

5

Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.

Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D. Cacicedo J, et al. Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24. Clin Transl Oncol. 2017. PMID: 28540535

6

Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.

Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R. Chaput A, et al. Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263422

7

Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.

Lin P, Min M, Lee M, Holloway L, Forstner D, Bray V, Fowler A. Lin P, et al. Eur J Nucl Med Mol Imaging. 2017 May;44(5):801-811. doi: 10.1007/s00259-016-3584-1. Epub 2016 Dec 21. Eur J Nucl Med Mol Imaging. 2017. PMID: 28004135

8

Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.

Katsuura T, Kitajima K, Fujiwara M, Terada T, Uwa N, Noguchi K, Doi H, Tamaki Y, Yoshida R, Tsuchitani T, Fujita M, Yamakado K. Katsuura T, et al. Ann Nucl Med. 2018 Aug;32(7):453-462. doi: 10.1007/s12149-018-1267-7. Epub 2018 Jun 1. Ann Nucl Med. 2018. PMID: 29858797

9

Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.

De Cuypere M, Lovinfosse P, Gennigens C, Hermesse J, Rovira R, Duch J, Goffin F, Hustinx R, Kridelka F. De Cuypere M, et al. Int J Gynecol Cancer. 2020 Nov;30(11):1705-1712. doi: 10.1136/ijgc-2020-001676. Epub 2020 Oct 8. Int J Gynecol Cancer. 2020. PMID: 33033165

10

Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.

Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Naganawa S, Hasegawa Y, Nakashima T. Suzuki H, et al. Ann Nucl Med. 2014 May;28(4):356-62. doi: 10.1007/s12149-014-0817-x. Epub 2014 Feb 11. Ann Nucl Med. 2014. PMID: 24515867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year